-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Siludi Pharmaceutical Co., Ltd. (01244.HK) issued an announcement regarding the latest developments in the dispute between the company and SELLAS Life Sciences Group, Inc. (SELLAS). The sole arbitrator made a final ruling, completely rejecting all arbitration claims brought by SELLAS, and also ruled that SELLAS must bear the company's total expenses relating to this arbitration of HK$7.983 million. The board of directors of the company is pleased to announce that the company has received the full amount of the above payment and that the arbitration award has been fully executed.

Zhitongcaijing·08/18/2026 04:57:06
Listen to the news
Zhitong Finance App News, Siludi Pharmaceutical Co., Ltd. (01244.HK) issued an announcement regarding the latest developments in the dispute between the company and SELLAS Life Sciences Group, Inc. (SELLAS). The sole arbitrator made a final ruling, completely rejecting all arbitration claims brought by SELLAS, and also ruled that SELLAS must bear the company's total expenses relating to this arbitration of HK$7.983 million. The board of directors of the company is pleased to announce that the company has received the full amount of the above payment and that the arbitration award has been fully executed.